Clinical Trials Directory

Trials / Unknown

UnknownNCT02074111

Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to investigate the proportion of patients with moyamoya disease among the patients who were diagnosed as having intracranial atherosclerotic stroke. To do this, biomarkers (gene and imaging) for moyamoya disease are tested and follow up angiography are performed during follow up (in selected patients).

Detailed description

1. Purpose Both moyamoya disease (MMD) and intracranial atherosclerotic stenosis (ICAS) are more prevalent in Asians than in Westerners, although the reason for the race-ethnic differences is unsettled. It is possible that patients with adult-onset MMD were misclassified as having ICAS, which may in part explain the high prevalence of intracranial atherosclerosis in Asians. It is important to differentiation between these two diseases because MMD and ICAS have differential therapeutic strategies (surgical revascularization in MMD vs. the use of antithrombotics/statins and stenting in ICAS). The ring finger 213 (RNF213) was recently identified as a susceptibility gene for MMD in East Asians. Characteristic high-resolution (HR) MRI findings of MMD and ICAS have recently been reported. The aim of this study is to investigate the proportion of patients with moyamoya disease among the patients who were diagnosed as having intracranial atherosclerotic stroke. To do this, biomarkers (gene and imaging) for moyamoya disease are tested and follow up angiography are performed during follow up (in selected patients). 2. Conditions: Stroke, intracranial occlusive lesion 3. Intervention: None 4. Study period: Jan 22, 2014 \~ Dec 31, 2016 5. Study design: Observational model Time perspective: Retrospective-Prospective

Conditions

Timeline

Start date
2014-01-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2014-02-28
Last updated
2017-04-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02074111. Inclusion in this directory is not an endorsement.